The current work extends these findings by demonstrating that resveratrol, a natural FASN inhibitor, suppresses both FASN expression and enzymatic activity, leading to apoptotic cell death across various breast cancer subtypes, independent of baseline FASN expression levels. Here, FASN is linked to breast cancer.